NLS Pharmaceutics AG: NLS Pharmaceutics Reports Positive Res

ZÜRICH, SWITZERLAND / ACCESSWIRE / May 28, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company dedicated to pioneering therapies

Related Keywords

Switzerland , United States , Miami , Florida , Swiss , American , Eric Konofal , European Medicines Agency , Company Contacts , Exchange Commission , Pharmaceutics Ltd , American Society Of Clinical Psychopharmacology , Nasdaq , American Society , Clinical Psychopharmacology , Chief Scientific Officer , Nocturnal Activity , Orexinb Saporin Induced Narcoleptic Like Model , Dependent Response , Activity Monitoring , Orphan Disease Designation , Mazindol Controlled Release , Orphan Drug Designations , Ihr Portfolio ,